Abiologics' Mike Hamill on Protein Medicines That Biology Can't Get Its Hands On

Following our latest deep dive on The Labs Report Substack, "Protein Medicines That Biology Can't Get Its Hands On,"Avak Kahvejian sits down with Abiologics Chief Innovation Officer Mike Hamill for the story behind the data — exploring how AI, protein design, and novel chemistry converged to create a new generation of biologics.